Validation of DAPPER for 3D QSAR: Conformational Search and Chirality Metric
暂无分享,去创建一个
[1] Martin Saunders,et al. Conformations of cycloheptadecane. A comparison of methods for conformational searching , 1990 .
[2] Gordon M. Crippen. VRI: 3D QSAR at variable resolution , 1999, J. Comput. Chem..
[3] A Tropsha,et al. Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. , 1996, Journal of medicinal chemistry.
[4] Gordon M Crippen,et al. Three-dimensional molecular descriptors and a novel QSAR method. , 2002, Journal of molecular graphics & modelling.
[5] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[6] R. Langridge,et al. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships. , 1989, Journal of medicinal chemistry.
[7] Irwin D. Kuntz,et al. ELECT++: Faster conformational search method for docking flexible molecules using molecular similarity , 1998, J. Comput. Chem..
[8] John Bradshaw,et al. Similarity and Dissimilarity Methods for Processing Chemical Structure Databases , 1998, Comput. J..
[9] R. Langridge,et al. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. , 1984, Journal of medicinal chemistry.
[10] Gilles Moreau,et al. Atomic Chirality, a Quantitative Measure of the Chirality of the Environment of an Atom , 1997, J. Chem. Inf. Comput. Sci..
[11] J M Blaney,et al. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis. , 1982, Journal of medicinal chemistry.
[12] Andrew Smellie,et al. Poling: Promoting conformational variation , 1995, J. Comput. Chem..
[13] Dorica Mayer,et al. A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies , 1987, J. Comput. Aided Mol. Des..
[14] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[15] S. Stanley Young,et al. Automated Pharmacophore Identification for Large Chemical Data Sets. , 1999 .
[16] Vladimir Prelog,et al. Specification of Molecular Chirality , 1966 .
[17] V. Kuz'min,et al. Quantitative aspects of chirality. I. Method of dissymmetry function , 1992 .
[18] Gordon M. Crippen,et al. Evaluation of Ligand Overlap by Atomic Parameters , 2001, J. Chem. Inf. Comput. Sci..
[19] W G Richards,et al. Molecular similarity, quantitative chirality, and QSAR for chiral drugs. , 1994, Journal of medicinal chemistry.
[20] C. Ingold,et al. The specification of asymmetric configuration in organic chemistry , 1956, Experientia.
[21] D. Ferguson,et al. A new approach to probing conformational space with molecular mechanics: Random incremental pulse search , 1989 .
[22] M C Nicklaus,et al. Conformational changes of small molecules binding to proteins. , 1995, Bioorganic & medicinal chemistry.
[23] Xin Chen,et al. Automated Pharmacophore Identification for Large Chemical Data Sets1 , 1999, J. Chem. Inf. Comput. Sci..